NICE is a provider of health guidance and information services for medical and social care professionals... Read more
NICE is a provider of health guidance and information services for medical and social care professionals... Read more
News
Apr 25, 2025
Medthority
National Institute for Health and Care Excellence: NICE (UK) positive for Rubraca (rucaparib) for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy
Apr 25, 2025
Medthority
National Institute for Health and Care Excellence: NICE (UK) recommends Joenja (leniolisib) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over
Apr 24, 2025
Pharmabiz
National Institute for Health and Care Excellence: Pharming receives positive recommendation from NICE for Joenja to treat APDS in adult and paediatric patients 12 years of age and older
Apr 24, 2025
The Pharmaceutical Journal
National Institute for Health and Care Excellence: NICE reverses draft guidance to recommend targeted therapy for patients with advanced bowel cancer
Apr 24, 2025
Pharmaceutical Business Review
National Institute for Health and Care Excellence: NICE issues final guidance endorsing Pharming's APDS therapy
Apr 23, 2025
Pharmafile
National Institute for Health and Care Excellence: Dual immunotherapy for bowel cancer now available under NHS
Apr 19, 2025
Medthority
National Institute for Health and Care Excellence: NICE Recommends Jakafi for Graft-Versus-Host Disease
Apr 17, 2025
Digital Health
National Institute for Health and Care Excellence: NICE approves 11 robotic surgery systems for use in the NHS
Apr 17, 2025
The Pharmaceutical Journal
National Institute for Health and Care Excellence: NICE recommends cladribine for treating active relapsing forms of multiple sclerosis
Apr 14, 2025
Medthority
National Institute for Health and Care Excellence: NICE Updates Crysvita Guidance
